• Adapting cancer civil society organizations to accelerate COVID-19 vaccinations in people living with cancer in low- and middle-income countries—A commentary
  Author:  Munisamy et al.
  Date:  22-Jul-21
  Journal: JCO Global Oncology
   
• Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination
  Author:  Robinson et al.
  Date:  22-Jul-21
  Journal: JAMA Oncology
   
• Refusal of anti-COVID-19 vaccination in cancer patients: is there a difference between the sexes?
  Author:  Stoekle et al.
  Date:  21-Jul-21
  Journal: European Journal of Cancer
   
• Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
  Author:  Greenberger et al.
  Date:  21-Jul-21
  Journal: Cancer Cell
   
• Cancer patients and internal medicine patients attitude towards COVID-19 vaccination in Poland
  Author:  Kufel-Grabowska et al.
  Date:  20-Jul-21
  Journal: Advances in Clinical and Experimental Medicine
   
• Understanding COVID-19 vaccine hesitancy and resistance: Another challenge in cancer patients
  Author:  Mejri et al.
  Date:  19-Jul-21
  Journal: Supportive Care in Cancer 
   
• COVID-19 vaccine safety in cancer patients: A single centre experience
  Author:  So et al.
  Date:  16-Jul-21
  Journal: Cancers
   
• SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit
  Author:  Nigro et al.
  Date:  15-Jul-21
  Journal: Pediatric Blood & Cancer
   
• Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
  Author:  Cuneo et al.
  Date:  13-Jul-21
  Journal: Hematological Oncology
   
• Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups
  Author:  Whitaker et al.
  Date:  09-Jul-21
  Journal: n/a
   
• COVID-19 vaccination in oncology patients receiving chemotherapy
  Author:  Mungmungpuntipantipa and Wiwanitkit.
  Date:  09-Jul-21
  Journal: Clinical Oncology
   
• Vaccination of cancer patients against COVID-19: Towards the end of a dilemma
  Author:  Mandal et al.
  Date:  08-Jul-21
  Journal: Medical Oncology
   
• Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
  Author:  Goshen-Lago et al.
  Date:  08-Jul-21
  Journal: JAMA Oncology
   
• Immunogenicity of COVID-19 vaccination in immunocompromised patients: An observational, prospective cohort study interim analysis
  Author:  Haidar et al.
  Date:  30-Jun-21
  Journal: medRxiv
   
• Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination
  Author: Luo et al.
  Date:  30-Jun-21
  Journal: Future Oncology
   
• COVID-19 vaccine hesitancy among adolescent and young adult cancer survivors
  Author:  Waters et al.
  Date:  29-Jun-21
  Journal: JNCI Cancer Spectrum
   
• Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
  Author:  Van Oekelen et al.
  Date:  28-Jun-21
  Journal: Cancer Cell
   
• Covid-19 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up - a monocenter study
  Author:  Placke et al.
  Date:  26-Jun-21
  Journal: European Journal of Cancer
   
• COVID-19 vaccine development from the perspective of cancer patients
  Author:  He et al.
  Date:  25-Jun-21
  Journal: Human Vaccines & Immunotherapeutics 
   
• BNT162b2 mRNA Covid-19 Vaccine in AYA with cancer: A monocentric experience
  Author:  Revon-Riviere et al.
  Date:  23-Jun-21
  Journal: European Journal of Cancer
   
• COVID-19 vaccination and breast cancer surgery timing
  Author:  Ko et al.
  Date:  22-Jun-21
  Journal: Breast Cancer Research and Treatment
   
• COVID-19 vaccination in patients on rituximab: A survey of lymphoma physicians at NCI designated cancer centers
  Author:  Messmer and Wagner-Johnston.
  Date:  21-Jun-21
  Journal: Leukemia & Lymphoma 
   
• Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
  Author:  Barrière et al.
  Date:  18-Jun-21
  Journal: European Journal of Cancer
   
• Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
  Author:  Addeo et al.
  Date:  18-Jun-21
  Journal: Cancer Cell
   
• Emerging issues related to COVID-19 vaccination in patients with cancer
  Author:  Saini et al.
  Date:  16-Jun-21
  Journal: Oncology and Therapy
   
• Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms
  Author:  Chowdhury et al.
  Date:  16-Jun-21
  Journal: British Journal of Haematology
   
• Serological response to COVID-19 vaccination in patients with cancer older than 80 years
  Author:  Iacano et al.
  Date:  11-Jun-21
  Journal: Journal of Geriatric Oncology
   
• Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
  Author:  Romano et al.
  Date:  11-Jun-21
  Journal: Journal for ImmunoTherapy of Cancer
   
• High levels of anti-SARS-CoV-2 IgG antibodies in previously infected cancer patients after a single dose of BNT 162b2 vaccine
  Author:  Fong et al.
  Date:  11-Jun-21
  Journal: European Journal of Cancer
   
• Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer
  Author:  Villarreal-Garza et al.
  Date:  10-Jun-21
  Journal: JAMA Oncology
   
• COVID-19 vaccination in patients with Classic Kaposi’s sarcoma
  Author:  Indini et al.
  Date:  10-Jun-21
  Journal: Vaccines
   
• Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity on imaging
  Author:  Emin et al.
  Date:  10-Jun-21
  Journal: JAMA Oncology
   
• COVID-19 vaccination among minority Cancer Patients: Recommendation of the International Geriatric Radiotherapy group
  Author:  Nguyen et al.
  Date:  07-Jun-21
  Journal: Archives of Clinical and Biomedical Research
   
• Seroconversion rates following COVID-19 vaccination amongst patients with cancer
  Author:  Thakkar et al.
  Date:  05-Jun-21
  Journal: Cancer Cell
   
• COVID-19 vaccines in patients with cancer
  Author:  Trapani and Curigliano.
  Date:  01-Jun-21
  Journal: The Lancet Oncology
   
• COVID-19 vaccination in patients with multiple myeloma: Focus on immune response
  Author:  Ludwig et al.
  Date:  31-May-21
  Journal: American Journal of Hematology
   
• Immune responses to SARS-CoV-2 among patients with cancer
  Author:  Sun et al.
  Date:  28-May-21
  Journal: JAMA Oncology
   
• Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer
  Author:  Massarweh et al.
  Date:  28-May-21
  Journal: JAMA Oncology
   
• Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
  Author:  Au et al.
  Date:  26-May-21
  Journal: Nature Medicine
   
• The first report on Covid-19 vaccine refusal by cancer patients in Italy: Early data from a single-institute survey
  Author:  Di Noia et al.
  Date:  26-May-21
  Journal: European Journal of Cancer
   
• Adherence to COVID-19 vaccines in cancer patients: Promote it and make it happen!
  Author:  Curigliano and Eggermont.
  Date:  24-May-21
  Journal: European Journal of Cancer
   
• Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
  Author:  Pimpinelli et al.
  Date:  17-May-21
  Journal: Journal of Hematology & Oncology
   
• Immune responses to COVID-19 mRNA vaccines in patients with solid tumors on active, immunosuppressive cancer therapy
  uthor:  Shroff et al.
  Date:  14-May-21
  Journal:  medRxiv
   
• COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
  Author:  Roeker et al.
  Date:  13-May-21
  Journal:  Leukemia
   
• COVID-19 vaccines in patients with cancer—A welcome addition, but there is need for optimization
  Author:  Korompoli et al.
  Date:  13-May-21
  Journal:  JAMA Oncology
   
• Coordination and optimization of PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination
  Author:  McIntosh et al.
  Date:  11-May-21
  Journal: Cancer Treatment Reviews
   
• COVID-19 vaccines in older adults with cancer: A Young International Society of Geriatric Oncology perspective
  Author:  Loh et al.
  Date:  01-May-21
  Journal: The Lancet Health Longevity
   
• Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
  Author:  Palich et al.
  Date:  29-Apr-21
  Journal: Annals of Oncology
   
• Impaired immunogenicity of BNT162b2 anti SARS-CoV-2 vaccine in patients treated for solid tumors
  Author:  Barrière et al.
  Date:  27-Apr-21
  Journal: Annals of Oncology
   
• Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
  Author:  Monin et al.
  Date:  27-Apr-21
  Journal: The Lancet Oncology
   
• Cancer and COVID-19 vaccines: A complex global picture
  Author:  Yusuf et al.
  Date:  27-Apr-21
  Journal: The Lancet Oncology
   
• The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients
  Author:  Ozdemir et al.
  Date:  23-Apr-21
  Journal: Medical Oncology
   
• Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer
  Author:  Woodfield et al.
  Date:  23-Apr-21
  Journal: American Cancer Society Journals
   
• Cancer patients should be considered as a high risk priority target in the coronavirus disease 2019 vaccination process
  Author:  Souadka et al.
  Date:  20-Apr-21
  Journal: Journal of Surgical Oncology
   
• Reply to letter to editor “Cancer patients should be considered as a high‐risk priority target in the COVID‐19 vaccination process”
  Author:  Rajan et al.
  Date:  20-Apr-21
  Journal: Journal of Surgical Oncology
   
• Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
  Author:  Bird et al.
  Date:  19-Apr-21
  Journal: The Lancet Haematology
   
• Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
  Author:  Herishanu et al.
  Date:  16-Apr-21
  Journal: Blood
   
• COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases, and other serious comorbid conditions
  Author:  Tsai et al.
  Date:  09-Apr-21
  Journal: medRxiv
   
• Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
  Author:  Waissengrin et al.
  Date:  01-Apr-21
  Journal: The Lancet Oncology
   
• SARS-CoV-2 vaccination for patients with solid cancer: Review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER)
  Author:  Tougeron et al.
  Date:  01-Apr-21
  Journal: European Journal of Cancer
   
• Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
  Author:  Mansi et al.
  Date:  26-Mar-21
  Journal: European Journal of Cancer
   
• Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar
  Author:  Kelkar et al.
  Date:  25-Mar-21
  Journal: Healthcare
   
• COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
  Author:  Silvestris et al.
  Date:  17-Mar-21
  Journal: ESMO Open
   
• Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
  Author:  Monin-Aldama et al.
  Date:  17-Mar-21
  Journal: medRxiv
   
• COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
  Author:  Desai et al.
  Date:  15-Mar-21
  Journal: Nature Reviews Clinical Oncology
   
• COVID-19 vaccine hesitancy among blood cancer patients
  Author:  Conti et al.
  Date:  08-Mar-21
  Journal: Leukemia & Lymphoma Society
   
• Delaying second vaccine dose leaves cancer patients vulnerable to virus
  Author:  Irshad et al.
  Date:  11-Mar-21
  Journal: n/a
   
• COVID-19 vaccine prioritisation for medical students: The forgotten cohort?
  Author:  Lim et al.
  Date:  02-Mar-21
  Journal: Clincal Oncology
   
• Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients
  Author: Loupakis et al.
  Date:  26-Feb-21
  Journal: Critical Reviews in Oncology/Hematology
   
• COVID-19 vaccines for patients with cancer: Benefits likely outweigh risks
  Author:  Hwang et al.
  Date:  26-Feb-21
  Journal: Journal of Hematology & Oncology 
   
• Current perspectives: SARS-CoV-2 vaccines for cancer patients: A call to action
  Author:  Corti et al.
  Date:  24-Feb-21
  Journal: European Journal of Cancer
   
• Lymphadenopathy in COVID-19 vaccine recipients: Diagnostic dilemma in oncology patients
  Author:  Özütemiz et al.
  Date:  24-Feb-21
  Journal: Radiology
   
• SARS-CoV-2 vaccines in patients with multiple myeloma
  Author:  Gavriatopoulou et al
  Date:  17-Feb-21
  Journal: Hemasphere
   
• COVID-19 vaccination: The VOICE for patients with cancer
  Author:  van der Veldt et al.
  Date:  15-Feb-21
  Journal: Nature Medicine
   
• The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
  Author:  Garassino et al.
  Date:  11-Feb-21
  Journal: Annals of Oncology
   
• SARS-CoV-2 vaccination and phase 1 cancer clinical trials
  Author:  Yap et al.
  Date:  08-Feb-21
  Journal: The Lancet Oncology
   
• COVID vaccination in cancer patients: What vaccination priority strategies should there be?
  Author:  Silvestris et al.
  Date:  04-Feb-21
  Journal: Frontiers in Oncology
   
• Challenges and opportunities for COVID-19 vaccines in patients with cancer
  Author:  Kuderer et al.
  Date:  03-Feb-21
  Journal: Cancer Investigation
   
• Professionally responsible COVID-19 vaccination counseling of obstetric/gynecologic patients: Counseling patients about COVID-19 vaccination
  Author: Chervenak et al.
  Date:  01-Feb-21
  Journal:  American Journal of Obstetrics and Gynecology
   
• COVID-19, the future vaccine and what it means for cancer patients on immunotherapy
  Author:  El-Shakankery et al.
  Date:  01-Feb-21
  Journal: Frontiers in Oncology
   
• Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
  Author:  Barriere et al.
  Date:  29-Jan-21
  Journal: Annals of Oncology
   
• COVID-19 vaccines: Preparing for vaccination in the context of clinical oncology care
  Author:  Carr et al.
  Date:  22-Jan-21
  Journal: Clinical Journal of Oncology Nursing
   
• COVID-19 vaccine race: Watch your step for cancer patients
  Author:  Fanciullino et al.
  Date:  07-Dec-20
  Journal: British Journal of Cancer